STK17A 抗体 (AA 45-150)
Quick Overview for STK17A 抗体 (AA 45-150) (ABIN872906)
抗原
See all STK17A 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 45-150
-
预测反应
- Human,Mouse,Rat,Chicken,Rabbit
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from human DRAK1/STK17A
-
亚型
- IgG
-
-
anti-serine/threonine Kinase 17a (STK17A) (AA 301-413) antibody
STK17A 适用: 人 WB, ELISA, IHC (p), RNAi 宿主: 小鼠 Monoclonal 4D12 unconjugated
anti-serine/threonine Kinase 17a (STK17A) (AA 301-413) antibodySTK17A 适用: 人 WB, ELISA 宿主: 小鼠 Monoclonal 3G8 unconjugated
anti-serine/threonine Kinase 17a (STK17A) (AA 301-414) antibodySTK17A 适用: 人 WB, IHC (p), EIA 宿主: 小鼠 Monoclonal 4D12 unconjugated
anti-serine/threonine Kinase 17a (STK17A) (AA 1-414) antibodySTK17A 适用: 人 WB, IP 宿主: 兔 Polyclonal unconjugated
anti-serine/threonine Kinase 17a (STK17A) (AA 5-19) antibodySTK17A 适用: 人 WB, ICC 宿主: 兔 Polyclonal unconjugated
anti-serine/threonine Kinase 17a (STK17A) antibodySTK17A 适用: 人 WB, ICC, IF 宿主: 兔 Polyclonal unconjugated
anti-serine/threonine Kinase 17a (STK17A) antibodySTK17A 适用: 人 WB, IHC (p) 宿主: 兔 Polyclonal unconjugated
anti-serine/threonine Kinase 17a (STK17A) (C-Term) antibodySTK17A 适用: 人 WB, ELISA 宿主: 兔 Polyclonal unconjugated
anti-serine/threonine Kinase 17a (STK17A) (C-Term) antibodySTK17A 适用: 人, 犬, 马, Cow, 兔, 猴 WB 宿主: 兔 Polyclonal unconjugated
anti-serine/threonine Kinase 17a (STK17A) antibodySTK17A 适用: 人 DB 宿主: 小鼠 Monoclonal 3064C6a unconjugated
-
-
应用备注
-
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 μg/μL
-
缓冲液
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
有效期
- 12 months
-
-
- STK17A (serine/threonine Kinase 17a (STK17A))
-
别名
- STK17A
-
背景
-
Synonyms: DAP kinase-related apoptosis-inducing protein kinase 1, death-associated protein kinase-related 1, EC 2.7.11.1, Serine / threonine kinase 17a death associated protein kinase related 1, Serine/threonine kinase 17a, Serine/threonine protein kinase 17a, STK17 A, STK17A, ST17A_HUMAN.
Background: DRAK1 (DAP kinase-related apoptosis-inducing protein kinase 1) is a novel member of the ser/thr protein kinase family, which mediate apoptosis through their catalytic activities. The full-length cDNA encodes a deduced 414-amino acid protein with a molecular mass of 46.56 kD. DRAKs contain an N-terminal kinase domain and a C-terminal regulation domain. DRAK1 messenger RNA appears to be ubiquitously expressed in human tissues. Overexpression of DRAK1 induces apoptosis. It has been shown in vitro that DRAK1 is capable of autophosphorylation and of phosphorylating the myosin light chain as an exogenous substrate, and that the noncatalytic C terminus is crucial for full kinase activity.
-
基因ID
- 9263
抗原
-
